Document is current
Any future updates will be listed below
-
Authors
Schlack, Katrin
Machtens, Stefan
Kubin, Thomas
Ruhnke, Markus
Schulte, Clemens
Eisen, Anna
Osowski, Ulrike
Guenther, Silke
Kearney, Mairead
Lipp, Rainer
Schmitz, Stephan
- License Information
-
More Information
Article History
Received: 16 September 2024
Accepted: 1 February 2025
First Online: 5 March 2025
Declarations
:
: K.S. has served in speakers bureaus and consulting or advisory roles for AAA, Amgen, Apogepha, Astellas, AstraZeneca, Bayer, Bristol Myers Squibb (personal and institutional), Eisai, EUSA-Pharma, Fosanis, Ipsen, Janssen Cilag, Merck, MSD, Novartis (personal and institutional), Pfizer (personal and institutional), and Roche, and has received travel, accommodations, and expenses from Astellas, AstraZeneca, Bayer, Janssen Cilag, Ipsen, Merck, and Sanofi-Aventis. S.M. has served in consulting or advisory roles for Amgen, AstraZeneca, Bayer, BD, Bebig, Janssen-Cilag, MSD, Pfizer, and Sanofi-Aventis, and has participated in speakers bureaus for Amgen, Apogepha, Astellas, AstraZeneca, Bayer, BD, Bebig, Ipsen, Janssen-Cilag, Merck, MSD, Novartis, Pfizer, Sanofi-Aventis, and Takeda. T.K. has served in speakers bureaus and consulting or advisory roles for AstraZeneca, BMS, Boehringer-Ingelheim, GSK, Janssen, MSD, Roche, and Takeda. M.R., C.S., and A.E. have nothing to disclose. U.O. reports employment with Merck Healthcare Germany GmbH, Weiterstadt, Germany, an affiliate of Merck KGaA. S.G. reports employment with Merck Healthcare KGaA, Darmstadt, Germany when the study was conducted. M.K. reports employment with Merck Healthcare KGaA, Darmstadt, Germany and reports stock and other ownership interests with Merck, Novartis, and UCB. R.L. has served in consulting or advisory roles for AstraZeneca, Gilead, Janssen-Cilag, Merck, Omnicare, Sanofi, and Takeda; has served in a speakers bureau for Merck; and has provided project support for AbbVie, AstraZeneca, Bristol Myers Squibb, Gilead, Janssen-Cilag, Merck, and Pfizer. S.S. has nothing to disclose.
: The study protocol was submitted to the independent ethical committee of the Chamber of Physicians in Northern Rhine, which confirmed that because data were fully anonymized, patient informed consent was not required. The protocol was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice Guidelines.
